Literature DB >> 7632141

Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma.

J Emond1, M E Wachs, J F Renz, S Kelley, H Harris, J P Roberts, N L Ascher, R C Lim.   

Abstract

BACKGROUND: Total vascular exclusion (TVE) of the liver has been used to increase the safety of hepatectomy and the feasibility of difficult resections. Until recently, however, concern about the detrimental effect of warm ischemia has limited the use of this technique to patients with normal liver parenchyma.
OBJECTIVE: To compare surgical outcomes of 12 patients with abnormal livers (group 1) with outcomes of 48 patients with normal parenchyma (group 2), based on the hypothesis that uncontrolled bleeding may be more detrimental than planned hepatic ischemia. DESIGN AND
SETTING: Retrospective analysis of 60 consecutive patients undergoing liver resection under TVE in a university medical center. PATIENTS: All 10 patients with cirrhosis had albumin levels of 30 g/L or higher and normal prothrombin times preoperatively; none had ascites. Two patients with cholestasis (one with cholangiocarcinoma and one with hepatocellular carcinoma) are included in group 1. INTERVENTION: All 12 group 1 patients and 44 of 48 group 2 patients underwent total or extended lobectomy, with TVE induced by clamping the hilum and the vena cava above and below the liver during parenchyma division. MAIN OUTCOME MEASURES: Hospital survival and selected surgical and laboratory parameters.
RESULTS: Operative times, ischemic times, and blood loss (1975 +/- 1601 vs 1255 +/- 1291 mL) (P = .10) were comparable in both groups. Sixty-day operative mortality was zero in both groups. There was an increased rate of complications in group 1 (44% vs 17% [P = 0.06]). Transient abnormal liver function was observed in both groups. However, significant delay in restoration of normal function was observed in group 1 with respect to bilirubin levels and prothrombin time.
CONCLUSIONS: Patients with cirrhosis can undergo successful resection using TVE. This conclusion must be limited to cirrhotic patients with good liver function. The trend toward increased blood loss may reflect greater difficulties in establishing hemostasis after reperfusion in group 1. While this group appears to have a higher risk for hepatic insufficiency, successful outcomes were achieved in all cases. Prospective study will be required to define the parameters for use of TVE in cirrhosis.

Entities:  

Mesh:

Year:  1995        PMID: 7632141     DOI: 10.1001/archsurg.1995.01430080026003

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  13 in total

1.  Liver resection using total vascular exclusion, scalpel division of the parenchyma, and a simple compression technique for hemostasis and biliary control.

Authors:  P D Hansen; A M Isla; N A Habib
Journal:  J Gastrointest Surg       Date:  1999 Sep-Oct       Impact factor: 3.452

2.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Superior approach for the exclusion of hepatic veins in major liver resection: a safe and easy technique.

Authors:  Aijun Li; Zeya Pan; Weiping Zhou; Siyuan Fu; Yuan Yang; Gang Huang; Lei Yin; Longjiu Cui; Bowen Wu; Mengchao Wu
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

4.  Liver transection using vascular stapler: a review.

Authors:  Peter Schemmer; Helge Bruns; Jürgen Weitz; Jan Schmidt; Markus W Büchler
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

5.  Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study.

Authors:  J Belghiti; R Noun; E Zante; T Ballet; A Sauvanet
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

6.  A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes.

Authors:  Jean C Emond; Benjamin Samstein; John F Renz
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

7.  Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.

Authors:  Tian Yang; Jin Zhang; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu; Wei-Feng Yu
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

8.  Hepatic resection using intermittent vascular inflow occlusion and low central venous pressure anesthesia improves morbidity and mortality.

Authors:  H Chen; N B Merchant; M S Didolkar
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

9.  Complex hepatectomy under total vascular exclusion of the liver: impact of ischemic preconditioning on clinical outcomes.

Authors:  Jangyong Jeon; Anthony Watkins; Gebhard Wagener; Benjamin Samstein; James Guarrera; Michael Goldstein; Joseph Meltzer; Tomoaki Kato; Jean C Emond
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

10.  Multiple gene differential expression patterns in human ischemic liver: safe limit of warm ischemic time.

Authors:  Qi-Ping Lu; Ting-Jia Cao; Zhi-Yong Zhang; Wei Liu
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.